Shares of Novo Nordisk, maker of Wegovy, rise after approval of GLP-1 pill
Novo Nordisk shares rose more than 7% on Tuesday after the Wegovy maker secured approval for its GLP-1 pill, a…
Novo Nordisk A/S
FDA approves first GLP-1 obesity pill from Wegovy maker Novo Nordisk
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, outside Copenhagen, Denmark, on…
Nine pharmaceutical companies sign agreements with Trump to lower drug prices
US President Donald Trump speaks during an event in the Roosevelt Room of the White House on December 19, 2025…
Eli Lilly's Anti-Obesity Pill Maintains Weight Loss After Wegovy, Zepbound
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…
Anti-obesity pills from Novo Nordisk and Eli Lilly arrive
Daniel Grill tetra images | fake images A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing…
Pfizer reaches agreement with YaoPharma for an anti-obesity pill
Pfizer CEO Albert Bourla speaks during a press conference with European Commission President Ursula von der Leyen after a visit…
Zealand Pharma unveils 2030 plan as weight loss competition heats up
Celsopupo | Stock | fake images Zealand Pharma outlined an ambitious five-year strategy for its anti-obesity portfolio on Thursday, highlighting…
Eli Lilly's weight-loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Eli Lilly cuts cash prices on vials of weight-loss drug Zepbound
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Eli Lilly reaches $1 trillion market value, first for a healthcare company
A sign with the company's logo sits outside Eli Lilly's headquarters in Indianapolis, Indiana, on March 17, 2024. Scott Olson…